1 / 17

Atrial Fibrillation

Atrial Fibrillation. Cardiovascular ISCEE 26 th October 2010. How might AF present in GP?. People with an irregular pulse +/- Breathlessness Palpitations Chest discomfort Syncope/dizziness Reduced exercise tolerance, malaise or polyuria

rianna
Télécharger la présentation

Atrial Fibrillation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Atrial Fibrillation • Cardiovascular ISCEE • 26th October 2010

  2. How might AF present in GP? • People with an irregular pulse +/- • Breathlessness • Palpitations • Chest discomfort • Syncope/dizziness • Reduced exercise tolerance, malaise or polyuria • A potential complication of AF such as stroke, TIA or heart failure

  3. Absence of an abnormal pulse makes a diagnosis of AF unlikely • But its presence does not reliably indicate AF. • Suspect paroxysmal AF if symptoms are episodic and last less than 48 hours.

  4. What do we need to do with them? • ECG to confirm diagnosis • If paroxysmal AF suspected and 12-lead ECG is normal then arrange ambulatory electrocardiography • Bloods • CXR

  5. TFTs – exclude hyperthyroidism • FBC – exclude anaemia • U&Es, Bone Profile, Glucose – exclude electrolyte disturbances which may precipitate AF • LFTs and clotting screen – assess suitability for warfarin • CXR – exclude lung abnormality such as lung cancer, also to detect heart failure

  6. Which ones need to be referred? • Urgently • Patients with: • Pulse > 150 bpm and/or low BP (systolic less than 90 mmHg) • Loss of consciousness, severe dizziness, ongoing chest pain or increasing breathlessness • A complication of AF – stroke, TIA, acute HF

  7. Which ones need to be referred? • Outpatients • New onset AF + • Young patient (age less than 50 yrs) • Suspected paroxysmal AF • Concurrent valve disease • LV systolic dysfunction on echo • Wolff-Parkinson-White syndrome or a prolonged QT interval is suspected on the ECG • Heart rate is difficult to control • Person continues to have symptoms despite rate control treatment

  8. Rhythm vs Rate • Rhythm control preferred treatment for paroxysmal AF and in people with persistent AF with any of the following: • Symptomatic • < 65 yrs of age • First presentation with lone AF • AF secondary to a treated or corrected precipitant (eg infection) • Congestive heart failure • Rate controlled preferred treatment for permanent AF and in people with persistent AF and any of the following: • > 65 yrs age • Coronary artery disease • Contraindications to antiarrhythmic drugs • Unsuitable for cardioversion

  9. GP Management • Rate control can be started in primary care • Beta-blockers, rate-limiting Ca-channel blockers, digoxin) • But rhythm control should only be done under specialist supervision • Amiodarone, fleicanide, sotalol • Start rate-control anyway if the person does not need admission but • Resting pulse >/= 90 bpm • Heart rate is fast on exertion, resulting in limited exercise tolerance

  10. Initial Rate Control Treatment • Beta-blocker or rate limiting Ca-channel blocker (diltiazem or verapamil) unless this is contraindicated • Choice between the 2 groups depends on current medication and co-morbidities • Diltiazem preferred to verapamil because verapamil has a greater negative inotropic effect and interacts with digoxin • Digoxin suitable for older sedentary people in whom rate control is not needed during exercise

  11. Subsequent Management • Review within 1 week – is the patient tolerating the drug? Review symptoms, heart rate, BP. • If drug not tolerated, prescribe an alternative. If symptoms not controlled, either increase dose or consider combination treatment. • To control symptoms during normal activities only, use beta-blocker/Ca-blocker with digoxin. • To control symptoms normal activities AND during exercise, use Ca-blocker with digoxin.

  12. Subsequent Management • Do not use a beta-blocker and Ca-blocker to control AF in primary care • If symptoms are not controlled by beta-blocker plus digoxin OR Ca-blocker plus digoxin refer to cardiology

  13. Antithrombotic Treatment • Everyone with AF (paroxysmal, persistent, permanent) should be offered antithrombotic treatment to reduce their risk of stroke • Offer either aspirin or warfarin without delay after confirming a diagnosis of AF • Choice should be based on person’s risk of stroke • Assess bleeding risk, likelihood of compliance with treatment and preferred options • Low risk of stroke – aspirin • Moderate risk of stroke – either aspirin or warfarin • High risk of stroke – warfarin

  14. Assessing Bleeding Risk • Factors that increase risk of bleeding • Age > 75yrs • Use of antiplatelet drugs • Use of NSAIDs • Polypharmacy • Uncontrolled hypertension • Hx of bleeding (bleeding peptic ulcer, cerebral haemorrhage) • Hx of previous poorly controlled anticoagulation therapy

  15. Assessing Stroke Risk • High risk • Previous ischaemic stroke / TIA or thromboembolic event • > 75yrs age with risk factors (hypertension, diabetes, coronary artery disease, peripheral artery disease) • Clinical evidence of valve disease or heart failure • Impaired LV function on echo • Moderate risk • > 65yrs age without risk factors • < 75yrs age with risk factors • Low risk • < 65yrs age without risk factors

  16. CHADS2 • Congestive heart failure = 1 • Hypertension (or treated hypertension) = 1 • Age older than 75 years = 1 • Diabetes mellitus = 1 • previousStroke or TIA = 2 • Treat with aspirin if total score is 0 or 1 • Use warfarin if score is 2 or more

  17. References • NICE 2006 ‘Atrial Fibrillation’ • Clinical Knowledge Summaries: ‘Atrial Fibrillation’

More Related